PPARG and pulmonary arterial hypertension: In addition, PAH in a rat model of MCT-PAH was treated by the Cat S inhibitor Millipore-219393, which stimulates PPARγ to inhibit Cat S expression, thus suppressing the proliferation and migration of PASMCs to reduced RVSP in this model [22].